Information service on treatment for rare diseases: the National Information Center for Orphan Drugs and Rare Diseases.
The amount of information available on rare diseases and the drug products used to treat them increases every year. The Orphan Drug Act, enacted in 1983, not only stimulated the development of orphan-drug products but also empowered the Food and Drug Administration to assist in the dissemination of information on these products to all health-care professionals. As the health-care professionals legally responsible for the dispensing of all drugs, pharmacists especially must be as informed as possible about any medication dispensed by them to their patients. The growing list of orphan-drug products makes this an almost impossible task. To assist in accessing this information, a new resource has been created.
Malcolm
L M
LM
D004345:Drug Industry; D007255:Information Services; D009965:Orphan Drug Production; D014481:United States; D014486:United States Food and Drug Administration